mbiome
Skin MicrobiomeEvidence briefing

Acne and the Microbiome: What the Research Shows

Acne is far more than a teenage nuisance — it affects 85% of people at some point. Emerging research suggests the skin and gut microbiome play a bigger role than previously thought.

By the mbiome editorial team4 min readPublished 8 April 2026
At a glance
Reading time
4 min
Last updated
8 Apr 2026
Acne and the Microbiome: What the Research Shows

Acne vulgaris is the most common skin condition worldwide, affecting an estimated 85% of people between the ages of 12 and 24. While hormones and genetics remain the primary drivers, research increasingly points to the microbiome — both skin and gut — as a significant contributing factor.

The Role of Cutibacterium acnes

For decades, Cutibacterium acnes (formerly Propionibacterium acnes) was cast as the villain of acne. The standard treatment approach was simple: kill the bacteria with antibiotics or benzoyl peroxide.

Modern genomic research has complicated this picture considerably. C. acnes is actually the dominant bacterium on healthy facial skin, and its presence is not inherently problematic. A study by Fitz-Gibbon et al. (2013, Journal of Investigative Dermatology) used metagenomic analysis to show that specific strains of C. acnes — particularly phylotype IA1 — are associated with acne, while other strains are found predominantly on healthy skin.

The issue is not the presence of C. acnes but rather which strains dominate and whether the broader microbial community is in balance. Acne-associated strains produce higher levels of inflammatory molecules, while health-associated strains appear to support normal skin function.

Microbiome Imbalance and Acne

Research by Dreno et al. (2017, Journal of the European Academy of Dermatology and Venereology) found that acne is characterised by a loss of microbial diversity on the skin surface. When S. epidermidis and other beneficial commensals are reduced, pathogenic C. acnes strains can dominate.

This is a pattern familiar from gut microbiome research — dysbiosis rather than infection. The immune system's response to this imbalance drives the inflammation, redness, and scarring that characterise acne.

Several factors contribute to this imbalance:

  • Excess sebum production (driven by androgens) alters the microenvironment, favouring lipophilic bacteria
  • Antibiotic use — both topical and oral — can eliminate protective species alongside problematic ones
  • Diet — high-glycaemic diets increase insulin-like growth factor 1 (IGF-1), promoting sebum production and inflammation
  • Skincare products that disrupt the skin's natural pH

The Gut-Acne Connection

The gut microbiome also influences acne through the gut-skin axis. Stokes and Pillsbury first proposed this connection in 1930, and modern research has validated their hypothesis. A study by Deng et al. (2018, Dermatology) found that patients with acne had significantly lower gut microbial diversity compared to controls, with reduced Lactobacillus and Bifidobacterium species.

The proposed mechanism involves gut-derived systemic inflammation. When the intestinal barrier is compromised, bacterial fragments enter the bloodstream and trigger inflammatory cascades that manifest at the skin. Ultra-processed diets that harm the gut microbiome may therefore contribute to acne through this indirect pathway.

Probiotic Treatments for Acne

Oral Probiotics

Several studies have investigated oral probiotics for acne with mixed but promising results. A randomised controlled trial by Jung et al. (2013, Nutrition) found that a Lactobacillus-fermented dairy drink reduced inflammatory acne lesions by 40% over 12 weeks compared to a non-fermented placebo.

A meta-analysis by Cater et al. (2022, JAMA Dermatology) reviewed 14 studies and concluded that oral probiotics showed "potential benefit" for acne, but noted significant heterogeneity between studies and a lack of standardised protocols.

Topical Probiotics

Topical application of beneficial bacteria is an emerging area. Research by Brüggemann (2020) explored applying S. epidermidis strains that produce antimicrobials specifically targeting acne-associated C. acnes strains. This approach is elegant in principle — using the skin's own ecology to restore balance — but remains experimental.

A pilot study by Kang et al. (2009, Journal of Microbiology) tested a lotion containing Enterococcus faecalis on acne patients and found a 50% reduction in inflammatory lesions compared to placebo. However, the sample size was small and larger trials are needed.

Practical Advice

While waiting for more definitive evidence, the following approaches are supported by current research:

  • Support gut health through diet — A high-fibre, low-glycaemic diet rich in vegetables, fruits, and fermented foods supports both gut and skin microbiome health
  • Avoid unnecessary antibiotics — If antibiotics are prescribed for acne, ask about the shortest effective course and consider microbiome recovery strategies afterwards
  • Use gentle cleansers — Harsh products and over-washing strip away beneficial skin bacteria. See our guide to skin microbiome basics for practical skincare tips
  • Consider the evidence for specific strains — If trying a probiotic for acne, look for strains with at least some clinical evidence (Lactobacillus rhamnosus, L. plantarum) rather than generic formulations
  • Be patient — Skin microbiome interventions typically take 8–12 weeks to show effects

The Bottom Line

Acne is not caused by "dirty skin" or a single bacterial species. It is a complex inflammatory condition influenced by hormones, genetics, diet, and the balance of microbial communities on the skin and in the gut. Research suggests that supporting microbial diversity — rather than aggressively trying to sterilise the skin — may be a more effective long-term strategy. The science is promising but still evolving, and the most proven interventions remain dietary improvement and targeted dermatological treatments.

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your diet, starting supplements, or making decisions about your health.

Reference layer

Key Terms

Glossary terms mentioned in this article

Staphylococcus epidermidis

One of the most abundant commensal bacteria on human skin. S. epidermidis produces antimicrobial peptides that inhibit pathogenic bacteria including S. aureus, communicates with the immune system, and helps maintain the skin's acidic pH. Often called the "good staph."

Lactobacillus rhamnosus

One of the most extensively studied probiotic species. The strain L. rhamnosus GG has strong evidence for preventing antibiotic-associated diarrhoea and acute gastroenteritis in children. The strain L. rhamnosus JB-1 has shown anxiolytic effects in animal models via the vagus nerve, though human trials have been less conclusive.

Cutibacterium acnes

The dominant bacterium on the human face (formerly classified as Propionibacterium acnes). It metabolises sebum and helps maintain the skin's acid mantle. Certain strains are associated with acne vulgaris, while others are found on healthy skin — the issue is strain imbalance rather than the species itself.

Bifidobacterium

A genus of beneficial bacteria that dominates the infant gut and remains important throughout life. Various species (B. longum, B. infantis, B. breve) are among the most studied probiotics, with evidence for IBS, immunity, and infant health.

Lactobacillus

A genus of lactic acid-producing bacteria found naturally in the gut, mouth, and vaginal tract. Certain strains (L. rhamnosus GG, L. plantarum 299v) have strong clinical evidence for specific health benefits. Now reclassified into multiple genera including Lacticaseibacillus and Limosilactobacillus.

Microbiome

The complete collection of microorganisms (bacteria, viruses, fungi, archaea) and their genetic material within a specific environment, such as the human gut.

Probiotic

Live microorganisms which, when administered in adequate amounts, confer a health benefit on the host. Benefits are strain-specific, not species-wide.

Dysbiosis

An imbalance in the composition or function of the microbiome, typically characterised by reduced diversity, loss of beneficial bacteria, or overgrowth of potentially harmful species.

Medical disclaimer: The information on mbiome is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your diet or health routine.